IQVIA Digital Site Suite

51. Alnylam Puts Sites And Patients First With IQVIA Technologies Investigator Site Portal

    When Alnylam Pharmaceuticals began developing medicines for rare diseases with few or no treatment options, the company’s leaders knew they needed to design clinical trials that kept patient well-being and disease burden at the forefront.